Hain Lifescience SA (Proudly a Bruker Company)

What Hain Lifescience SA (Proudly a Bruker Company) does

Hain Lifescience GmbH is a German molecular diagnostics company headquartered in Nehren, Germany, operating as a subsidiary of Bruker Corporation and marketed as "Proudly a Bruker Company." The company develops and commercializes multiplex PCR-based in vitro diagnostic (IVD) products built on its proprietary LiquidArray technology, which combines fluorescent probe-based detection with multiplexed reaction chemistry to identify multiple pathogens simultaneously. Its product portfolio spans a FluoroCycler XT real-time PCR instrument, the newly launched GenoXtract fleXT automated nucleic acid extraction instrument, and a menu of FluoroType and LiquidArray syndromic reagent kits covering sexually transmitted infections (7 pathogens), gastrointestinal infections (26 pathogens), mycobacteria (32 NTM species plus TB), and respiratory pathogens (SARS-CoV-2, influenza A/B, RSV).

The company serves clinical and microbiology laboratories worldwide, with products distributed "all over the world" through a global distributor network, supplemented by direct website sales and presence at industry exhibitions. Its revenue model is a two-stream instrument-plus-consumables structure: capital revenue from instrument placements (FluoroCycler XT, GenoXtract fleXT) and recurring revenue from reagent kit consumption, with pricing not publicly disclosed.

Operating with a small organization of approximately 23 employees, Hain Lifescience functions as a focused product unit within the larger Bruker Corporation rather than a standalone enterprise, benefiting from parent-level resources, distribution channels, and R&D infrastructure while maintaining its distinct syndromic PCR brand identity.

Name

Hain Lifescience SA (Proudly a Bruker Company)

Legal name

Hain Lifescience GmbH

Website

https://hain-lifescience.co.za

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Hain Lifescience GmbH is a German molecular diagnostics subsidiary of Bruker Corporation that develops multiplex PCR-based syndromic test panels (STI, GI, mycobacteria, respiratory) and proprietary instruments (FluoroCycler XT, GenoXtract fleXT), serving clinical and microbiology laboratories worldwide through a global distributor network.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro industry

PRIMARYHLAHAAAD

Molecular Diagnostics (PCR/NAAT/NGS-based IVD)

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

SECONDARYHLAGAIAF

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Equipment, Instruments & Consumables

SECONDARYHLAAALAC

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

Keywords

• Molecular diagnostics
• Multiplex PCR tests
• Syndromic testing panels
• Infectious disease diagnostics
• Clinical microbiology reagents

Headquarters

HQ city

Nehren

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Diagnostic Instruments and Equipment: Sale of proprietary diagnostic instruments including the FluoroCycler XT and GenoXtract fleXT systems for laboratory use.
2. Diagnostic Reagent Kits: Sale of PCR test kits and reagents for various infectious disease applications including STI, gastrointestinal, mycobacteria, and respiratory virus diagnostics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Hain Lifescience develops, manufactures, and sells molecular diagnostic products built on its proprietary LiquidArray multiplex PCR technology. The portfolio includes the FluoroCycler XT real-time PCR instrument and GenoXtract fleXT extraction system, alongside FluoroType and LiquidArray reagent kits for syndromic detection of sexually transmitted infections, gastrointestinal pathogens, mycobacteria (NTM and M. tuberculosis complex), and respiratory viruses (SARS-CoV-2, Influenza, RSV). Products are sold to clinical and microbiology laboratories worldwide through a global distributor network.

Product overview

Hain Lifescience offers a portfolio of molecular diagnostics products centered on its proprietary LiquidArray technology. The core product line includes the FluoroCycler XT instrument as the hardware platform, which runs various FluoroType and LiquidArray PCR-based diagnostic tests. Key product categories include sexually transmitted infection panels (FluoroType STI), gastrointestinal pathogen panels (LiquidArray Gastrointestinal), mycobacteria identification tests (FluoroType Mycobacteria), and respiratory virus detection kits (SARS-CoV-2/Influenza/RSV). The company also provides the GenoXtract fleXT extraction and PCR set-up accessory. All products are based on multiplex PCR technology with syndromic panel capabilities for laboratory diagnostics.

Differentiator

Problem solved

Functional benefit

Products and services

• FluoroCycler XT Real-time PCR instrument that serves as the only platform supporting the proprietary LiquidArray multiplex PCR technology; used by clinical and microbiology laboratories to run FluoroType and LiquidArray diagnostic test kits.
• GenoXtract fleXT Automated extraction and PCR set-up device that processes original patient specimens directly for FluoroType SARS-CoV-2 assays, enabling streamlined laboratory workflow without manual extraction steps.
• FluoroType STI Multiplex PCR diagnostic test using LiquidArray technology for simultaneous detection of up to 7 sexually transmitted infection pathogens in a single reaction; intended for clinical microbiology laboratories performing syndromic STI screening.
• LiquidArray Gastrointestinal Next-generation multiplex syndromic PCR panel for the detection of up to 26 gastrointestinal pathogens from a single patient sample; designed for clinical laboratories performing comprehensive GI infection workups.
• FluoroType Mycobacteria

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Bruker CorporationflagshipStrategic or Co-development PartnerHain Lifescience is a Bruker Company, operating as a subsidiary of Bruker Corporation, a leading global manufacturer of scientific instruments. This acquisition integrates Hain Lifescience's molecular diagnostics expertise in multiplex PCR technology with Bruker's broader scientific instrumentation portfolio. The company email domain uses bruker.com indicating operational integration.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• Cepheid (Danaher): Cepheid's GeneXpert and Xpress systems deliver automated, cartridge-based multiplex molecular diagnostics (e.g., Xpert Xpress respiratory, CT/NG) directly competing with Hain's syndromic PCR kits in clinical laboratories.
• BioFire Diagnostics (bioMérieux): BioFire's FilmArray system is the leading multiplex PCR syndromic panel platform in clinical microbiology (e.g., Blood Culture Identification, GI, Respiratory panels), competing head-to-head with Hain's LiquidArray and FluoroType offerings for the same hospital and reference lab customers.
• Hologic: Hologic's Panther Fusion system provides fully automated multiplex molecular testing for respiratory viruses and other pathogens, competing with Hain's FluoroCycler XT-based assays in mid- to high-throughput hospital labs.
• Abbott Molecular: Abbott's m2000 and Alinity m systems run real-time PCR infectious disease assays, providing competing molecular diagnostic solutions to the same clinical and microbiology lab customers targeted by Hain.
• Seegene: Seegene develops multiplex real-time PCR syndromic assays (Allplex respiratory, GI, STI panels) sold globally through partner channels, directly overlapping with Hain's syndromic infectious disease test portfolio.
• ELITech Group: ELITech (including ELITech Molecular, formerly Elitech/Epoch) offers real-time PCR kits and instruments (e.g., InGenius) for infectious disease diagnostics, competing with Hain's FluoroType range in smaller hospital and reference laboratories.
• QIAGEN: QIAGEN's QIAstat-Dx platform offers syndromic multiplex PCR panels (respiratory, GI, meningitis/encephalitis) overlapping directly with Hain's test menu, and the company also supplies sample-prep technologies used alongside molecular diagnostics workflows.

Broad incumbents

• Roche Diagnostics: Roche's cobas systems for PCR-based infectious disease testing (viral loads, CT/NG, MTB) serve the same hospital and reference lab market as Hain, though as a broad incumbent with a much larger diagnostics portfolio beyond multiplex panels.
• Bruker Corporation: Bruker is Hain Lifescience's parent and broader peer in the life-science instrumentation market; while Bruker is not a direct molecular-diagnostics competitor to its own subsidiary, its MALDI Biotyper and broader microbiology franchise creates portfolio-level overlap with Hain's customer base.

Emerging players

• Molbio Diagnostics: Molbio's Truenat platform delivers chip-based, near-POC real-time PCR testing for TB, HIV, HPV and other pathogens, partially overlapping with Hain's mycobacteria and infectious disease molecular menu but targeting decentralized settings.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/hain-lifescience-sa

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hain Lifescience SA (Proudly a Bruker Company)